文献速递消化内镜消化道肿瘤与早癌

为何尝试对无蒂结直肠腺瘤行整块切除?内镜黏膜下剥离术后浅层黏膜下浸润癌患病率的系统综述

Why attempt en bloc resection of non-pedunculated colorectal adenomas? A systematic review of the prevalence of superficial submucosal invasive cancer after endoscopic submucosal dissection.
PubMed 文献 · Gut · 2017-12-05

该系统综述纳入51项研究、11260个结直肠内镜黏膜下剥离(ESD)切除病灶,评估浅层黏膜下浸润癌(SMIC SM1,浸润深度≤1000 µm)的患病率。结果SMIC SM1仅占8.0%(95%CI 6.1%至10.3%),避免一次手术的需治疗人数(NNT)为12.5;对恶性病灶估计治愈性切除率75.3%时,治愈性切除患病率降至6%(95%CI 4.2%至7.2%),NNT为16.7。作者认为SMIC SM1患病率低且治愈性切除率更低,限制了内镜整块切除的临床适用性。

要点

  • 51项研究、11260个ESD切除结直肠病灶中,腺瘤占82.2%(低级别26.8%、高级别55.4%)。
  • 黏膜下癌占15.7%,其中浸润深度≤1000 µm的SMIC SM1仅占8.0%(95%CI 6.1%至10.3%)。
  • 避免一次手术的NNT为12.5;治愈性切除患病率6%时NNT为16.7。

核心结论

  • ESD所选病灶中SMIC SM1患病率低,且治愈性切除率更低,限制了内镜整块切除的临床适用性。
  • 作者呼吁对结直肠肿瘤切除中不加选择地使用该技术保持谨慎。

研究设计与样本

  • 系统综述,检索电子数据库至2017年3月,纳入报告ESD切除病灶组织学的结直肠ESD系列研究。
  • 共纳入51项研究,涉及11260个结直肠ESD切除病灶。

主要发现

  • 切除病灶中腺瘤占82.2%(95%CI 78.8%至85.3%),低级别和高级别异型增生分别占26.8%和55.4%。
  • 黏膜下癌占15.7%,其中浸润深度≤1000 µm者仅占8.0%(95%CI 6.1%至10.3%),避免一次手术的NNT为12.5。
  • 对恶性病灶估计治愈性(R0;G1/2;L0/V0)切除率为75.3%(95%CI 52.2%至89.4%),治愈性切除患病率降至6%(95%CI 4.2%至7.2%),NNT为16.7。

关键数值与推荐

  • SMIC SM1定义为浸润深度≤1000 µm或不足黏膜下层的三分之一。
  • 治愈性切除定义为R0、G1/2、L0/V0。

临床怎么用

  • 作者认为SMIC SM1患病率低及治愈性切除率更低,限制了内镜整块切除的临床适用性。
  • 作者呼吁对结直肠肿瘤切除中不加选择地使用ESD保持谨慎。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endoscopic submucosal dissection (ESD) aims to achieve en bloc resection of non-pedunculated colorectal adenomas which might be indicated in cases with superficial submucosal invasive cancers (SMIC), but the procedure is time consuming and complex. The prevalence of such cancers is not known but may determine the clinical necessity for ESD as opposed to the commonly used piecemeal mucosal resection (endoscopic mucosal resection) of colorectal adenomas. The main aim was to assess the prevalence of SMIC SM1 (ie, invasion ≤1000 µm or less than one-third of the submucosa) on colorectal lesions removed by ESD. DESIGN: A literature review was conducted using electronic databases (up to March 2017) for colorectal ESD series reporting the histology of the dissected lesions. RESULTS: 51 studies with data on 11 260 colorectal dissected lesions were included. Most resected lesions (82.2%; 95% CI 78.8% to 85.3%) were adenomas (low- and high-grade dysplasia, 26.8% and 55.4%, respectively). Overall, 15.7% were submucosal cancers, but only slightly more than half (8.0%; 95% CI 6.1% to 10.3%) had an infiltration depth of ≤1000 µm, providing a number needed to treat (NNT) to avoid one surgery of 12.5. Estimating an oncologically curative (R0; G1/2; L0/V0) resection rate of 75.3% (95% CI 52.2% to 89.4%) for malignant lesions, the prevalence of curative resection lowered to 6% (95% CI 4.2% to 7.2%) with an NNT of 16.7. CONCLUSION: The low prevalence of SMIC SM1 in lesions selected for ESD as well as the even lower rate of curative resection limits the clinical applicability of endoscopic en bloc resection. This calls for caution over an indiscriminate use of this technique in the resection of colorectal neoplasia.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Fuccio L, Repici A, Hassan C, et al. Why attempt en bloc resection of non-pedunculated colorectal adenomas? A systematic review of the prevalence of superficial submucosal invasive cancer after endoscopic submucosal dissection. Gut. 2017. PMID: 29208675. doi:10.1136/gutjnl-2017-315103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。